HomeOLMA • NASDAQ
add
Olema Pharmaceuticals Inc
Previous close
$4.12
Day range
$4.03 - $4.29
Year range
$3.94 - $16.62
Market cap
289.05M USD
Avg Volume
810.11K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 36.77M | 20.88% |
Net income | -33.57M | -25.38% |
Net profit margin | — | — |
Earnings per share | -0.51 | -4.08% |
EBITDA | -36.67M | -20.92% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 434.09M | 65.80% |
Total assets | 450.98M | 62.84% |
Total liabilities | 42.02M | 82.28% |
Total equity | 408.96M | — |
Shares outstanding | 65.79M | — |
Price to book | 0.66 | — |
Return on assets | -26.99% | — |
Return on capital | -30.16% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -33.57M | -25.38% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2006
Headquarters
Website
Employees
88
